Evidence map›Paper›PMID 34211552›Full record

ArticleJournal of oncology2021

Protective Effect of Quercetin Nanoemulsion on 5-Fluorouracil-Induced Oral Mucositis in Mice.

Mandana Lotfi, Sohrab Kazemi, Anahita Ebrahimpour, Fatemeh Shirafkan, Marzieh Pirzadeh, Mohammad Hosseini, Ali Akbar Moghadamnia

Open access · hybridAbstract read
In one paragraph

Article in Journal of oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. The Brown Strain ofInternational journal of molecular sciences · 2026
    Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. The protective effects of silymarin nanoemulsion on 5-fluorouracil-induced gastrointestinal toxicity in rats.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2023
    Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Mandana LotfiStudent Research Committee, Health Research Center, Babol University of Medical Sciences, Babol, Iran.
Sohrab KazemiCellular and Molecular Biology Research Center, Health Research Center, Babol University of Medical Sciences, Babol, Iran.ORCID https://orcid.org/0000-0002-8068-5745
Anahita EbrahimpourCellular and Molecular Biology Research Center, Health Research Center, Babol University of Medical Sciences, Babol, Iran.
Fatemeh ShirafkanCellular and Molecular Biology Research Center, Health Research Center, Babol University of Medical Sciences, Babol, Iran.
Marzieh PirzadehStudent Research Committee, Health Research Center, Babol University of Medical Sciences, Babol, Iran.
Mohammad HosseiniDepartment of Veterinary Pathology, Babol-Branch, Islamic Azad University, Babol, Iran.
Ali Akbar MoghadamniaCellular and Molecular Biology Research Center, Health Research Center, Babol University of Medical Sciences, Babol, Iran.ORCID https://orcid.org/0000-0001-7140-1352
Babol University of Medical Sciences · IRIslamic Azad University, Babol

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The target of this study was to evaluate the efficacy, histopathological, oxidative stress, and molecular effects of quercetin (QRC) in mice with oral mucositis induced by 5-fluorouracil (5-FU). Thirty-six albino male mice with oral mucositis induced by 5-FU as a chemotherapeutic agent were used in this study. The animals were randomly divided into 6 groups: control group, mucositis (MUC) group, pretreatment group, posttreatment group, and two last groups including nanoemulsion form of QRC with a dose of 5 mg/kg in both pretreatment and posttreatment. In the present evaluation, fewer oral lesions were observed in the QRC posttreatment groups compared to the pretreatment and nanoemulsion receiving groups. In the SOD assay, the most significant difference was observed in the posttreatment nanogroup (41.073 ± 1.24) and pretreatment nanogroup (43.453 ± 2.60) in comparison to the 5-FU group (30.897 ± 1.93). The results of CAT assay also showed a significant difference in nano-posttreatment (124.60 ± 10.85), posttreatment (135.4 ± 9.82), and nano-pretreatment groups (128.80 ± 7.20) compared to the 5-FU group (55.07 ± 8.91). The expression of inflammatory genes such as Hif-1

Identifiers

PMID34211552
PMCPMC8208858
OpenAlexW3173070407

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.